AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 132.66 Increased By ▲ 3.13 (2.42%)
BOP 6.89 Increased By ▲ 0.21 (3.14%)
CNERGY 4.57 Decreased By ▼ -0.06 (-1.3%)
DCL 8.92 Decreased By ▼ -0.02 (-0.22%)
DFML 42.75 Increased By ▲ 1.06 (2.54%)
DGKC 84.00 Increased By ▲ 0.23 (0.27%)
FCCL 32.90 Increased By ▲ 0.13 (0.4%)
FFBL 77.06 Increased By ▲ 1.59 (2.11%)
FFL 12.20 Increased By ▲ 0.73 (6.36%)
HUBC 110.01 Decreased By ▼ -0.54 (-0.49%)
HUMNL 14.40 Decreased By ▼ -0.16 (-1.1%)
KEL 5.53 Increased By ▲ 0.14 (2.6%)
KOSM 8.32 Decreased By ▼ -0.08 (-0.95%)
MLCF 39.67 Decreased By ▼ -0.12 (-0.3%)
NBP 65.50 Increased By ▲ 5.21 (8.64%)
OGDC 198.74 Decreased By ▼ -0.92 (-0.46%)
PAEL 26.00 Decreased By ▼ -0.65 (-2.44%)
PIBTL 7.62 Decreased By ▼ -0.04 (-0.52%)
PPL 159.00 Increased By ▲ 1.08 (0.68%)
PRL 26.24 Decreased By ▼ -0.49 (-1.83%)
PTC 18.35 Decreased By ▼ -0.11 (-0.6%)
SEARL 82.24 Decreased By ▼ -0.20 (-0.24%)
TELE 8.12 Decreased By ▼ -0.19 (-2.29%)
TOMCL 34.40 Decreased By ▼ -0.11 (-0.32%)
TPLP 8.98 Decreased By ▼ -0.08 (-0.88%)
TREET 16.88 Decreased By ▼ -0.59 (-3.38%)
TRG 59.49 Decreased By ▼ -1.83 (-2.98%)
UNITY 27.52 Increased By ▲ 0.09 (0.33%)
WTL 1.40 Increased By ▲ 0.02 (1.45%)
BR100 10,614 Increased By 206.9 (1.99%)
BR30 31,874 Increased By 160.5 (0.51%)
KSE100 98,972 Increased By 1644 (1.69%)
KSE30 30,784 Increased By 591.7 (1.96%)
Nov 22, 2024 اردو ► PRINT EDITION ► BR MARKETS ► Dollar to PKR ►

drugmakers

Novavax expects COVID-19 vaccine supply in Japan well into 2022
Business & Finance

Novavax expects COVID-19 vaccine supply in Japan well into 2022

  • Takeda Pharmaceutical Co, Japan's biggest drugmaker, is helping bring the vaccine to the domestic market.
  • The Japanese drugmaker plans to make about 250 million doses of the Novavax vaccine in Japan every year and is receiving funding from Japan's Health, Labour and Welfare ministry to ramp up production.
Published 07 May, 2021 06:41pm
AstraZeneca's lower EU vaccine supply target hinges on factory approval: document
Business & Finance

AstraZeneca's lower EU vaccine supply target hinges on factory approval: document

  • The Anglo-Swedish drugmaker said on Friday it would try to deliver 30 million doses to the EU by the end of March, down from a contractual obligation of 90 million and a previous pledge made last month to deliver 40 million doses.
  • AstraZeneca said in the document seen by Reuters that it is assuming the Halix factory will get the green light on March 25 and has pencilled in deliveries of nearly 10 million doses for the following week.
Updated 13 Mar, 2021 09:10pm
S. Africa's Aspen forecasts 16-18pc sales growth for half year ended December
Business & Finance

S. Africa's Aspen forecasts 16-18pc sales growth for half year ended December

  • The company, which could produce Johnson & Johnson's COVID-19 vaccine by end-March, said revenue from continuing operations is expected to grow between 16% and 18% for the six months ended Dec. 31.
  • Aspen, which also manufactures active ingredients used in medicines and helps in packaging and filling of final products, is due to report its financial results for half year ended Dec. 31 on March 11.
Published 23 Feb, 2021 09:09pm
India to start COVID-19 vaccine exports as soon as Wednesday
Business & Finance

India to start COVID-19 vaccine exports as soon as Wednesday

  • The first batch of exports will be shipped to the tiny nation of Bhutan, said the officials, who asked not to be named as the plans are not public.
  • India has received requests from dozens of nations, including urgent appeals from Brazil, to begin exports of the vaccine from the SII centre in the western city of Pune.
Published 19 Jan, 2021 06:19pm